-
OPTH share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of OPTH shares has decreased $0.09 since the market last closed. This is a 1.89% drop.
-
Last closed at $4.67.
The stock has since risen $0.13 in pre-market trading.
Key terms
About OPTH
Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.
-
Market cap: $37.41M
A market capitalization up to $300 million places OPTH in the micro-capitalization category.
Key terms
Smart score
Latest OPTH news
OPTH Financials
-
OPTH total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$2.65M (1Y), -$1.16M (Q2)
Net Income increased 40.14% since last year and decreased 4.13% since last quarter.
-
Earnings per share: -$0.83 (1Y), -$0.36 (Q2)
EPS increased 44.17% since last year and decreased 4.16% since last quarter.
Key terms
OPTH Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OPTH Competitors
-
How competitors are chosen
OPTH's competitors are included in the Process Industries sector and Agricultural Commodities/Milling group
-
Market cap: $37.41M
A market capitalization up to $300 million places OPTH in the micro-capitalization category.
